Radius Health Inc
NASDAQ:RDUS
Radius Health Inc
Inventory
Radius Health Inc
Inventory Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Inventory | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Radius Health Inc
NASDAQ:RDUS
|
Inventory
$273m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
11%
|
CAGR 10-Years
3%
|
|
|
Abbvie Inc
NYSE:ABBV
|
Inventory
$4.9B
|
CAGR 3-Years
16%
|
CAGR 5-Years
7%
|
CAGR 10-Years
10%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Inventory
$4.4B
|
CAGR 3-Years
43%
|
CAGR 5-Years
21%
|
CAGR 10-Years
8%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Inventory
$6.2B
|
CAGR 3-Years
8%
|
CAGR 5-Years
10%
|
CAGR 10-Years
10%
|
|
|
Astria Therapeutics Inc
NASDAQ:ATXS
|
Inventory
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Inventory
$1.7B
|
CAGR 3-Years
54%
|
CAGR 5-Years
43%
|
CAGR 10-Years
40%
|
|
Radius Health Inc
Glance View
Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company is headquartered in Boston, Massachusetts and currently employs 293 full-time employees. The company went IPO on 2014-06-06. The firm is focused on developing and commercializing endocrine therapeutics. Its lead product, TYMLOS (abaloparatide) injection, is a prescription medicine for the treatment of postmenopausal women with osteoporosis at high risk for fracture. The firm also has products in clinical pipeline, which includes investigational abaloparatide injection for potential use in the treatment of men with osteoporosis; an investigational abaloparatide patch for potential use in the treatment of postmenopausal women with osteoporosis; the investigational drug, elacestrant (RAD1901), for potential use in the treatment of hormone-receptor positive breast cancer out-licensed to Menarini Group, and RAD011, a synthetic cannabidiol oral solution that is being developed for the treatment of Prader-Willi syndrome (PWS).
See Also
What is Radius Health Inc's Inventory?
Inventory
273m
USD
Based on the financial report for May 31, 2025, Radius Health Inc's Inventory amounts to 273m USD.
What is Radius Health Inc's Inventory growth rate?
Inventory CAGR 10Y
3%
Over the last year, the Inventory growth was -18%. The average annual Inventory growth rates for Radius Health Inc have been -15% over the past three years , 11% over the past five years , and 3% over the past ten years .
